We are live on ! Find out more
RNAM

Avidity Biosciences
RNAM

Delisted

RNAM was delisted on the 26th of February, 2026.

Back to rankings

52 hedge funds and large institutions have $702M invested in Avidity Biosciences in 2020 Q2 according to their latest regulatory filings, with 52 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

67.87% more ownership

Funds ownership: 0% → 67.87% (+68%)

Holders
52
Holders Change
+52
Holders Change %
–
% of All Funds
1.07%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.08%
New
52
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RI
RTW Investments
New York
+$115M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$81.7M
3
CAM
Cormorant Asset Management
Massachusetts
+$72.5M
4
EC
EcoR1 Capital
California
+$60.7M
5
PA
Perceptive Advisors
New York
+$35.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RI
1
RTW Investments
New York
$104M +$115M +3,995,000 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$80.1M +$81.7M +2,832,852 New
CAM
3
Cormorant Asset Management
Massachusetts
$67.8M +$72.5M +2,514,547 New
EC
4
EcoR1 Capital
California
$59.5M +$60.7M +2,103,950 New
MCMC
5
Matrix Capital Management Company
New Hampshire
$33.9M +$34.6M +1,200,000 New
BC
6
Boxer Capital
California
$31.7M +$32.3M +1,121,327 New
PA
7
Perceptive Advisors
New York
$31.6M +$35.6M +1,235,818 New
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$26.9M +$27.4M +950,400 New
LGM
9
Logos Global Management
California
$25.6M +$26.7M +926,454 New
Victory Capital Management
10
Victory Capital Management
Texas
$25.2M +$25.7M +890,780 New
DM
11
Deerfield Management
New York
$24.8M +$25.3M +877,011 New
Wellington Management Group
12
Wellington Management Group
Massachusetts
$24.7M +$25.2M +875,088 New
Alkeon Capital Management
13
Alkeon Capital Management
New York
$21.9M +$22.3M +775,000 New
BlackRock
14
BlackRock
New York
$17M +$17.3M +600,000 New
ACA
15
Avoro Capital Advisors
New York
$16.5M +$16.9M +585,000 New
HA
16
HHLR Advisors
Cayman Islands
$12M +$12.3M +425,000 New
Federated Hermes
17
Federated Hermes
Pennsylvania
$10.5M +$10.7M +370,919 New
Janus Henderson Group
18
Janus Henderson Group
United Kingdom
$9.14M +$9.33M +323,603 New
Citadel Advisors
19
Citadel Advisors
Florida
$7.72M +$7.88M +273,220 New
Franklin Resources
20
Franklin Resources
California
$7.11M +$8.65M +300,000 New
Alyeska Investment Group
21
Alyeska Investment Group
Illinois
$6.97M +$7.12M +246,827 New
APM
22
Avidity Partners Management
Texas
$6.64M +$6.77M +234,814 New
Millennium Management
23
Millennium Management
New York
$6.39M +$6.52M +226,044 New
ACH
24
ArrowMark Colorado Holdings
Colorado
$5.65M +$5.77M +200,000 New
O
25
OrbiMed
New York
$5.65M +$5.77M +200,000 New
1
2 3

RNAM Hedge Fund Activity: Q2 2020 in Review

52 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Avidity Biosciences (RNAM) for Q2 2020, worth a combined $702M.

Buyers outnumbered sellers: 52 funds opened new RNAM positions and 0 closed out — a net gain of 52 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RTW Investments, opening a new position worth an estimated $115M.

  • 52 institutional investors held Avidity Biosciences (RNAM) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $702M of Avidity Biosciences stock for Q2 2020.
  • 52 funds opened new Avidity Biosciences positions in Q2 2020 and 0 closed out, a net change of +52 holders.
  • The largest Avidity Biosciences buyer in Q2 2020 was RTW Investments, an estimated $115M added.

Based on aggregated 13F filings for Q2 2020.